1-9 of 9
8p11 myeloproliferative syndrome
Close
Sort by
Journal Articles

Whole Genome Profiling of Adult B-Other Acute Lymphoblastic Leukaemia on the UKALL14 Trial

Daniel A. Leongamornlert, PhD, Emilio Barretta, Soo Lee, Thomas Creasey, MBBS, Rachel J. Mitchell, MSc, Amy A. Kirkwood, MSc, Laura Clifton-Hadley, PhDBSc, Pip Patrick, PhDMSc,MA, Peter J Campbell, Bela Wrench, MBBS, MD MRCP, FRCPath, Anthony V. Moorman, Adele K. Fielding, MBBS,PhDFRCP,FRCPath, Elli Papaemmanuil, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2743.
https://doi.org/10.1182/blood-2019-125723
Published: 2019
Journal Articles

First Description Of a t(10;11)(q22;q23)/ MLL-TET1 Reciprocal Translocation In a T Lymphoblastic Lymphoma With Subsequent Lineage Switch To Acute Myelomonocytic Myeloid Leukemia

Antoine Ittel, Eric Jeandidier, MD, Nathalie Perrusson, Catherine Humbrecht, Bruno Lioure, MD, Isabelle Mazurier, Caroline Mayeur-Rousse, Carine Gervais, MD, Catherine Helias, Sylvie Thiebault, MD, Felix Lerintiu, Laurent Mauvieux, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1357.
https://doi.org/10.1182/blood.V122.21.1357.1357
Published: 2013
Journal Articles

Combined Targeting of the MET and FGF Receptor Tyrosine Kinases Induces Sustained AML Cell Death by Preventing Compensatory Upregulation of HGF in Response to MET Kinase Inhibition

Alex Kentsis, MD, PhD, Takaomi Sanda, MD, PhD, Casie Reed, BS, Scott J. Rodig, MD, PhD, Eleni Tholouli, PhD, MRCPath, Vu Ngo, PhD, Jeffery Lorne Kutok, MD, PhD, Suzanne E. Dahlberg, PhD, Lisa A Moreau, PhD, George Vande Woude, PhD, James Christensen, MD, Richard Byers, PhD, MBChB, FRCPath, Andrew L. Kung, MD, PhD, Louis M. Staudt, MD., Ph.D., Thomas Look, MD
Journal: Blood
Blood (2011) 118 (21): 1405.
https://doi.org/10.1182/blood.V118.21.1405.1405
Published: 2011
Journal Articles

The Kinase Inhibitor TKI258 Is Active Against the Novel CUX1-FGFR1 Fusion Detected In a Patient with T-Lymphoblastic Leukemia/Lymphoma and t(7;8)(q22;p11)

Bartosz Wasag, PhD, Els Lierman, PhD, Peter Meeus, MD, Jan Cools, PhD, Peter Vandenberghe, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2715.
https://doi.org/10.1182/blood.V116.21.2715.2715
Published: 2010
Journal Articles

8p11–12 Myeloprolferative Syndrome: A Case Report and Brief Review of the Literature

Sarvari Venkata Yellapragada, MD, Martha P. Mims, MD, PhD, Courtney Jackson, MD, Mark Lewis, MD, Mark M. Udden, MD
Journal: Blood
Blood (2008) 112 (11): 5260.
https://doi.org/10.1182/blood.V112.11.5260.5260
Published: 2008
Journal Articles

Activity of TKI258 against primary cells and cell lines with FGFR1 fusion genes associated with the 8p11 myeloproliferative syndrome

Andrew Chase, Francis H. Grand, Nicholas C. P. Cross
Journal: Blood
Blood (2007) 110 (10): 3729–3734.
https://doi.org/10.1182/blood-2007-02-074286
Published: 2007
Journal Articles

Phosphotyrosine profiling identifies the KG-1 cell line as a model for the study of FGFR1 fusions in acute myeloid leukemia

Ting-Lei Gu, Valerie L. Goss, Cynthia Reeves, Lana Popova, Julie Nardone, Joan MacNeill, Denise K. Walters, Yi Wang, John Rush, Michael J. Comb, Brian J. Druker, Roberto D. Polakiewicz
Journal: Blood
Blood (2006) 108 (13): 4202–4204.
https://doi.org/10.1182/blood-2006-06-026666
Published: 2006
Includes: Supplemental data
Journal Articles

TKI258 (CHIR-258) Selectively Inhibits FGFR1 Fusion Genes Associated with the 8p11 Myeloproliferative Syndrome.

Andrew Chase, Francis H. Grand, Nicholas C.P. Cross
Journal: Blood
Blood (2006) 108 (11): 2699.
https://doi.org/10.1182/blood.V108.11.2699.2699
Published: 2006
Journal Articles

Consistent Fusion of ZNF198 to the Fibroblast Growth Factor Receptor-1 in the t(8;13)(p11;q12) Myeloproliferative Syndrome

Andreas Reiter, Jastinder Sohal, Shashikant Kulkarni, Andrew Chase, Donald H.C. Macdonald, Ricardo C.T. Aguiar, Cristina Gonçalves, Jesus M. Hernandez, Barbara A. Jennings, John M. Goldman, Nicholas C.P. Cross
Journal: Blood
Blood (1998) 92 (5): 1735–1742.
https://doi.org/10.1182/blood.V92.5.1735
Published: 1998